Artwork

Contenu fourni par Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !

Get To Know Cholangiocarcinoma with Dr. Javle

17:04
 
Partager
 

Manage episode 315211779 series 2861129
Contenu fourni par Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

As we continue our Cholangiocarcinoma Series I am excited to welcome to the show, Milind Javle, M.D.

Milind Javle is a medical oncologist from Houston, TX. He is currently the Hubert L. and Olive Stringer Professor at UT MD Anderson Cancer Center, he is also the current chair, NCI Task Force, Hepatobiliary Cancers, former chair of the International Cholangiocarcinoma Research Network, Vice President of the Cholangiocarcinoma Foundation: Clinical and Scientific Advisory Board. He graduated from Grant Medical College, Mumbai, India and completed his residency in SUNY, Buffalo, NY, and oncology training at Roswell Park Cancer Institute, NY. He has authored over 200 articles in peer-reviewed literature, has been the principal investigator for several phase 1-3 clinical trials and served in an advisory capacity to pharmaceutical companies, regulatory and networking bodies. He has held leadership positions in the American Society of Clinical Oncology and Hepatobiliary Conventions. He has led/ participated in pivotal clinical trial of infigratinib and ivosidenib which led to FDA approvals and is regarded as one of the international leaders in this field.

Listen in as Dr. Javle helps us Get to know Cholangiocarcinoma.

Learn More About Cholangiocarcinoma At: https://cholangiocarcinoma.org/

Visit http://www.onairadvocate.com for information on all of our products, services & resources.

  continue reading

100 episodes

Artwork
iconPartager
 
Manage episode 315211779 series 2861129
Contenu fourni par Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

As we continue our Cholangiocarcinoma Series I am excited to welcome to the show, Milind Javle, M.D.

Milind Javle is a medical oncologist from Houston, TX. He is currently the Hubert L. and Olive Stringer Professor at UT MD Anderson Cancer Center, he is also the current chair, NCI Task Force, Hepatobiliary Cancers, former chair of the International Cholangiocarcinoma Research Network, Vice President of the Cholangiocarcinoma Foundation: Clinical and Scientific Advisory Board. He graduated from Grant Medical College, Mumbai, India and completed his residency in SUNY, Buffalo, NY, and oncology training at Roswell Park Cancer Institute, NY. He has authored over 200 articles in peer-reviewed literature, has been the principal investigator for several phase 1-3 clinical trials and served in an advisory capacity to pharmaceutical companies, regulatory and networking bodies. He has held leadership positions in the American Society of Clinical Oncology and Hepatobiliary Conventions. He has led/ participated in pivotal clinical trial of infigratinib and ivosidenib which led to FDA approvals and is regarded as one of the international leaders in this field.

Listen in as Dr. Javle helps us Get to know Cholangiocarcinoma.

Learn More About Cholangiocarcinoma At: https://cholangiocarcinoma.org/

Visit http://www.onairadvocate.com for information on all of our products, services & resources.

  continue reading

100 episodes

모든 에피소드

×
 
Loading …

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

 

Guide de référence rapide